Verified Nov 2026
Other
·

Plano, Texas
·
Since 2002
Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.
Reata Pharmaceuticals, Inc. at a glance
Employees
200-500
Founded
2002
Headquarters
Plano, Texas
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.
At a glance
Attribute | Detail |
|---|---|
Founded | 2002 |
Headquarters | Plano, Texas |
Employees | 200-500 |
What Reata Pharmaceuticals, Inc. makes
Reata develops treatments through molecular pathway targeting, with omaveloxolone approved for Friedreich's ataxia and serialization compliance implemented for DSCSA and EU FMD regulations.
Latest developments
2026-05-15 — 🚨Healthcare M&A: Goldman Sachs and Lazard Advised on Biogen's Completed $7.1 Billion Acquisition of Reata Pharmaceuticals, Inc. | Krugman (linkedin.com)
2026-02-02 — Reata Pharmaceuticals Shifts Focus to Omaveloxolone Commercialization Following Friedreich's Ataxia Approval - MedPath Trial (medpath.com)
2025-07-17 — Phase 3 company Reata Pharmaceuticals (acquired by Biogen) partnered with TraceLink and NNIT to implement serialization tools that ensured compliance with both DSCSA and EU FMD—while navigating the path to commercial launch. | TraceLink (linkedin.com)
Facilities
Reata Pharmaceuticals, Inc. is headquartered in Plano, Texas. Public sources also reference these locations:
Irving, Texas — akta.pro
Company details
The company operates a facility in Irving, Texas, and now operates as part of Biogen following the 2026 acquisition. Reata Pharmaceuticals, Inc. was founded in 2002, has an estimated 200-500 employees, and is headquartered in Plano, Texas.
Frequently asked questions
What does Reata Pharmaceuticals, Inc. do?
Reata Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in Plano, Texas, with 200–500 employees. The company develops treatments for kidney disease, liver disease, and autoimmune conditions. In May 2026, Biogen completed a $7.1 billion acquisition of Reata, integrating its drug development capabilities into Biogen's portfolio. Reata serves healthcare providers and medical institutions managing serious diseases.
Where is Reata Pharmaceuticals, Inc. headquartered?
Reata Pharmaceuticals, Inc. is headquartered in Plano, Texas (5320 Legacy Drive, Plano, Texas, 75024).
When was Reata Pharmaceuticals, Inc. founded?
Reata Pharmaceuticals, Inc. was founded in 2002.
How big is Reata Pharmaceuticals, Inc.?
Reata Pharmaceuticals, Inc. has an estimated 200-500 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
